Fundraising Fox
🦊/People
Sign in

Marianne Uteng

Investor

Managing Director at Novartis Venture Fund

Basel, Switzerland

Writes $5M – $10M checks · typically $7.5M

Find your path to Marianne

132 people in our graph share verified history with Marianne — schools, employers, funds. One of them is your warm intro.

Dominic SchmidtunlockedMarianne: together at Amphista (2022–2026)
×2Marianne: together at Tagworks Pharmaceuticals
Marianne: together at Rappta
×5Marianne: together at University of Oslo

About

Marianne Uteng, PhD, is a Managing Director at Novartis Venture Fund in Basel. She previously worked in Novartis Global Drug Development and its Pre-Clinical Safety Department, leading teams on safety assessments for early and late-stage programs, and supported Novartis BD&L Search & Evaluation while building collaborations with biotech companies and academia. She holds an MSc in Biochemistry from the University of Oslo and a PhD in Molecular Biology, Cell Biology & Biophysics from a joint EMBL–University of Oslo program.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. NovartisManaging Director at Novartis Venture Fundcurrent2023 — presentBasel, Switzerland
  2. AstronauTxMember Board of Directorscurrent2023 — present
  3. Tagworks PharmaceuticalsMember Board of Directorscurrent2023 — presentNetherlands
  4. Epsilogen LtdBoard Directorcurrent2022 — presentUnited Kingdom
  5. CatalYm GmbHBoard Observercurrent2022 — presentMunich, Bavaria, Germany
  6. CatalYm GmbHBoard Director2021 — 2022Germany
  7. Amphista Therapeutics LimitedBoard Observercurrent2021 — presentGreater London, England, United Kingdom
  8. Rappta TherapeuticsBoard Observercurrent2020 — presentHelsinki, Uusimaa, Finland

Skills & more

Venture CapitalBiomarkers16Biotechnology5Biomarker Discovery3Clinical Development3Clinical Trials3Drug Development2Drug Discovery4In Vitro3Biochemistry8Lifesciences10Molecular Biology14
+10 moreNMROncologyPeptidesPharmaceutical IndustryStructure ElucidationToxicologyCellLife SciencesLaboratoryCell Biology

From Marianne's professional profile.

Investments

Per curated public sources.

Colleagues at Novartis Venture Fund

Adam Cotton
Principal at the Novartis Venture Fund
Anís
Head of Scoping, Pharma at Deep Science Ventures
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Campbell Murray
Advisor
Christoph Meier
Investor at Novartis Venture Fund

Frequently asked questions

Who is Marianne Uteng?
Marianne Uteng, PhD, is a Managing Director at Novartis Venture Fund in Basel. She previously worked in Novartis Global Drug Development and its Pre-Clinical Safety Department, leading teams on safety assessments for early and late-stage programs, and supported Novartis BD&L Search & Evaluation while building collaborations with biotech companies and academia. She holds an MSc in Biochemistry from the University of Oslo and a PhD in Molecular Biology, Cell Biology & Biophysics from a joint EMBL–University of Oslo program.
Where does Marianne Uteng work?
Marianne Uteng is Managing Director at Novartis Venture Fund.
What does Marianne Uteng invest in?
Marianne Uteng invests in Biotech.
What check size does Marianne Uteng write?
Marianne Uteng typically writes checks of $5M – $10M.
What companies has Marianne Uteng invested in?
Investments tracked here include AstronauTx, CatalYm, Epsilogen, Tagworks Pharmaceuticals.
Where did Marianne Uteng go to school?
Marianne Uteng studied at European Molecular Biology Laboratory (EMBL) (PhD, Cell Biology & Biophysics); University of Oslo (Master's degree, Biochemistry).

Same school

Shared employers